PTH Attenuation Trial in Hemodialysis-1

Condition:   Secondary Hyperparathyroidism Interventions:   Drug: PLS240;   Drug: Placebo;   Drug: Open-Label Extension PLS240 Sponsors:   Pathalys Pharma;   Launch Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials